Introduction
Adenomyosis preferentially affects parous women between the ages of 35 and 50 years. Several reports indicate that patients with adenomyosis have a high incidence of early miscarriage (Olive et al., 1982; Kano et al., 1997) . It is widely known that patients with adenomyosis often present with severe dysmenorrhoea and/or iron deficiency anaemia. The disease is characterized by ectopic growth of endometrial tissues within the myometrium as well as by a diffuse enlargement of the uterus. Thus, the only difference between adenomyosis and endometriosis is the site of endometriotic tissues, i.e. within or outside the uterus.
It is well known that endometriosis is a major cause of infertility and is probably provoked by the presence of ectopic endometrium. Endometriosis is accompanied by various autoimmune phenomena. It has been reported that patients with endometriosis have an increased number of macrophages in peritoneal fluid (Haney et al., 1981) which have increased activity (Halme et al., 1984) . Macrophages may secrete various cytokines including interleukin (IL)-1 and tumour necrosis factor (TNF) (Fakih et al., 1987; Halme, 1987; Unanue and Allen, 1987; Mori et al., 1990) . Furthermore, autoantibodies, particularly those against phospholipids, are present at increased concentrations in peripheral blood in endometriosis . These abnormal immune phenomena appear to play a pivotal role in infertility due to endometriosis. Similar abnormal immune phenomena have been noted in adenomyosis (Ota, 1991; Ota et al., 1992 Ota et al., , 1996a . The purpose of this article is to review the available information regarding the involvement of the immune system in adenomyosis and to discuss its role in reproductive physiology.
Expression of cell surface antigens Human leukocyte antigens (HLA) antigens
HLA are divided into three classes: class I, class II and class III antigens. Expression of class II antigen is considered to be an important step in the activation of macrophages and/ or T cells.
Recent studies indicate that many autoimmune diseases are associated with the presence of organ-specific autoantibodies in peripheral blood (Shoenfeld and Isenberg, 1989) . It is believed that the expression of class II antigen is a key process in the production of autoantibodies. Several reports indicate increased expression of the HLA-DR antigen in target organs in Graves' (Hanafusa et al., 1983) disease and diabetes mellitus (Bottazzo et al., 1985) . Exaggerated expression in target cells of the complex molecule of antigen peptides and HLA molecules is first recognized by macrophages, which subsequently activate T cells. Activated T cells secrete cytokines, which in turn stimulate B cells to produce immunoglobulins, i.e. autoantibodies.
In the human endometrium, HLA antigens are expressed throughout the menstrual cycle (Tabibzadeh et al., 1986a) . We have previously reported the increased expression of HLA antigens in eutopic and ectopic endometria, particularly in glandular epithelial cells, in adenomyosis and endometriosis (Ota and Igarashi, 1993) . This raises the question as to why and how the expression of HLA antigens is induced in these diseases. It has been widely observed that various cytokines are produced in endometriosis (Hill, 1995) . Among these, interferon-γ is known to stimulate the expression of class II antigen in endometrial cells (Tabibzadeh et al., 1986b) and thyroidal cells (Todd et al., 1985) . These facts suggest that substances liberated from the endometrium, especially the ectopic endometrium, are recognized by macrophages, which in turn activate helper T cells and stimulate B cells to produce antibodies. Thus, the expression of class II antigen in endometrial cells appears to play a critical role in immune reactions which occur in adenomyosis and endometriosis.
Integrins
The integrins are a family of cell surface receptors involved mainly in cell-matrix adhesion but also in certain cell-cell interactions (Helmer, 1990) . Integrins are heterodimeric transmembrane glycoproteins composed of α and β subunits (Ruoslahti, 1991) . The molecules are classified into seven subgroups according to the type of β subunit. Integrins are one of several families of adhesion molecules expressed in the human endometrium (Lessey et al., 1992) . Several reports indicate the abnormal expression of β1 or β3 integrins in the endometrium in endometriosis (Tabibzadeh, 1992; Bischof et al., 1993; Klentzeris et al., 1993; Lessey et al., 1994a,b; Van der Linden et al., 1994) , while the expression of the integrins in adenomyosis has been reported (Ota and Tanaka, 1997) . β1 integrins are characterized by very late activation (VLA) antigen molecules. The expression of integrins varies according to the phase of the menstrual cycle. Lessey et al. (1994b) reported that the expression of VLA-4 was significantly reduced in endometriosis compared with fertile controls. We have observed that the expression of VLA-4 in the secretory phase is reduced in adenomyosis (Ota and Tanaka, 1997) . One of the ligands for VLA-4 is fibronectin, which is produced in endometrial stromal cells (Siegfried et al., 1984) and acts as a 'molecular glue' during embryo implantation. A lack of endometrial αvβ3 integrin expression (vitronectin receptor) has been reported during the implantation window in patients with endometriosis (Lessey et al., 1994a) , suggesting that the integrin-fibronectin/vitronectin system plays a central role in embryo implantation.
Little is known regarding the regulation of integrin expression in the endometrium. Various immune cells and macrophages accumulate in the endometrial stroma, and, upon activation, secrete various cytokines and growth factors, including interleukin-1β and transforming growth factor (TGF)-β. Several studies have suggested that these cytokines may modulate the expression of integrins (Dedhar, 1989; Ignotz et al., 1989) . Altered integrin expression may inhibit both embryo implantation and subsequent embryonic development by adversely affecting the microenvironment of the endometrium.
Cadherin
The cadherins are a family of homodimeric glycoproteins acting as membrane receptors and divided into three subclasses, E-, N-and P-cadherins, on the basis of their tissue distribution. E-cadherin mediates cell-cell interaction, causing cells that express the same cadherin to adhere preferentially to each other (Takeichi, 1988) . Cadherins are distributed widely among animals and play a potentially significant role in morphogenic events during embryogenesis (Shirayoshi et al., 1983) . Cadherins are expressed in the cells bounding the endometrium (Inoue et al., 1992; Bischof et al., 1993; Van der Linden et al., 1994) . We have reported that the expression of E-cadherin in the endometrium was higher in the secretory phase than in the proliferative phase (Ota and Tanaka, 1997) , although other workers have reported that expression is unchanged during the cycle (Van der Linden et al., 1995) . The expression of E-cadherin in the endometrium in endometriosis and adenomyosis was significantly higher throughout the menstrual cycle than in control endometrium. It remains unclear why expression of some adhesion molecules is suppressed while that of other adhesion molecules is exag-gerated in the endometrium in endometriosis and adenomyosis. Further studies are needed to elucidate the exact role of adhesion molecules in the endometrium in adenomyosis.
Immunoglobulin superfamilies
The initiation of a specific immune response is believed to require not only activation through antigen-specific receptors present on T cells and B cells but also antigen-independent interactions between accessory molecules. Members of these immunoglobulin (Ig) superfamilies include lymphocyte-function-associated antigen-2 (LFA-2; CD2), LFA-3, and intercellular adhesion molecule-1 (ICAM-1). These molecules enhance the avidity of interactions between T cells and antigen-presenting cells (Dougherty et al., 1988; Altmann et al., 1989) and are potentially involved in signal transduction across the T cell membrane (Van Noesel et al., 1988) .
LFA-1, a member of the integrin family, is expressed by the majority of leukocytes (Sanchez-Madrid et al., 1982; Dougherty and Hogg, 1987) . ICAM-1, a ligand of LFA-1 (Dougherty et al., 1988) , is expressed by some lymphocytes, endothelial cells and fibroblasts (Tawia et al., 1993) , and has also been reported in stromal cells and endovascular cells in the human endometrium (Tawia et al., 1993) . Tabibzadeh and Poubouridis (1990) reported positive staining of ICAM-1 in glandular and luminal epithelial cells in the endometrium. Further, cytokines including interferon-γ or TNF were found to increase the intensity of staining of ICAM-1 in endothelial cells (Munro et al., 1989) . The secretion of cytokines by endometrial cells has been reviewed (Tabibzadeh, 1994) . LFA-2 is able to bind to LFA-3 with high affinity, and can mediate the adhesion of lymphocytes via interaction with LFA-3 (Shaw et al., 1986; Selvaraj et al., 1987) . We have shown great intensity of staining of the adhesion molecules LFA-1 and LFA-2 on T cells and ICAM-1 on the glandular cells in the endometria in adenomyosis (Ota et al., 1996b) . These findings indicate that activity of two accessory pathways, involving LFA-1/ICAM-1 and LFA-2/LFA-3, may be increased in adenomyosis. Thus, activity of three separate pathways of cell-cell interaction involving T cell receptor (TCR)/HLA, LFA-1/ICAM-1 and LFA-2/LFA-3 may strongly enhance the effect of antigen presentation, leading to abnormal immune phenomena in adenomyosis.
Activation of macrophages and immune cells Macrophages
Class II antigens are strongly expressed in endometriotic glandular cells in endometriosis and adenomyosis. Hence, the presence of endometriotic tissue may activate the autoimmune system in these diseases. However, the mechanisms by which macrophages are activated and autoantibodies are produced are still not clearly understood. Macrophages are widely distributed throughout the human body and have various functions: phagocytosis, presenting antigens to lymphocytes, and initiating antigenspecific immune responses. In addition, these cells monitor and protect the host against neoplastic cells and kill invading organisms. The antigen-presenting cell function of macrophages is mediated by class II MHC, including HLA-DR.
In endometriosis, macrophages in the peritoneal fluid are increased in number and activity (Haney et al., 1981; Halme et al., 1984) . Macrophages secrete various cytokines including IL-1 and TNF (Fakih et al., 1987; Halme, 1987; Mori et al., 1990) . In endometriosis, these cytokines may impede conception via several mechanisms, including sperm phagocytosis (Muscato et al., 1982) , decrease in sperm motility (Esue et al., 1982; Oak et al., 1985) , or interference with fertilization (Sueldo et al., 1986) or implantation (Hahn et al., 1986) . We have reported an increased number of macrophages in eutopic and ectopic endometria in adenomyosis , suggesting their possible involvement in the reduced fertility of patients with adenomyosis.
T cells
Human T cells are divided into two subtypes according to their receptors, i.e. αβT cells and γδT cells. αβT cells recognize fragments of foreign antigens associated with MHC molecules on the membrane of the antigen-presenting cells, and can be subdivided on the basis of expression of CD4 for class II MHC recognition and CD8 for class I MHC recognition. A number of leukocytes have been found scattered in the stroma of eutopic endometria (Tabibzadeh, 1990; Klentzeris et al., 1994) . Several studies have reported on the presence of T cell subpopulations in endometriosis. We reported that the number of T cell subtypes and macrophages in endometrial tissue from fertile patients showed no cycle-dependent differences (Ota et al., 1996a) . Witz et al. (1994) found that CD4, CD8 and VLA-1-positive, and therefore activated, T cells were increased in endometrial tissues in patients with endometriosis. This suggests that immune cells may be activated in the endometrium of patients with endometriosis.
γδT cells have no known ligand and have been found to express neither CD4 nor CD8 molecules, and hence recognize antigens without MHC restriction. γδT cells are located in the skin, small intestine, lung, uterus and ovary (Groh et al., 1989; Itohara et al., 1990; Nandi and Allison, 1991; Raulet et al., 1991) and function primarily in epithelial immune reactions (Bluestone and Matis, 1989; Raulet, 1989) . We have found that γδT cells are increased in eutopic and ectopic endometria in endometriosis and adenomyosis (Ota et al., 1996b) . Furthermore, It is also known that γδT cells are increased in several autoimmune diseases, including chronic rheumatoid arthritis (Réme et al., 1990) and in some types of inflammation of the bowel (Spencer et al., 1989; Trejdosiewicz et al., 1991) . Similar bleeding and/or necrosis may occur in endometriotic tissues in endometriosis and adenomyosis, leading to inflammatory reaction and stimulation of macrophages and γδT cells. Further, these cells may respond to the presence of stressed self-cells (Raulet, 1989) . Thus, activated cells secrete various cytokines, which stimulate the expression of HLA antigens on the surface of glandular cells.
B cells
The production of immunoglobulins by B cells is dependent on the presence of T cells. Activated T cells secrete various cytokines, which stimulate B cells to differentiate and produce immunoglobulins. Several reports have shown that B cells in peritoneal fluid are significantly elevated in women with endometriosis (Badawy et al., 1987; Hill et al., 1988) . Few studies have been conducted on the distribution of B cells in the endometrial stroma (Klentzeris et al., 1994) . Witz et al. (1994) found no cyclical changes in stained CD22 positive cells in the endometrium during the menstrual cycle, but noted that the number of B cells tended to increase in the endometriosis group compared with the controls. However, to date there have been no reports on B cells in adenomyosis.
Humoral factors Autoantibodies or immunoglobulins
It is well known that the peripheral blood concentrations of various autoantibodies, particularly those against phospholipids, are greatly increased in endometriosis and adenomyosis (Ota, 1991; Ota et al., 1992) . In adenomyosis, the most prevalent autoantibodies are anti-phosphatidylinositol IgG, anti-phosphatidylglycerol IgG and anti-phosphatidylserine IgG (Figure 1) . It is possible that the production of these autoantibodies is increased in the presence of endometriotic tissues. The number of patients with increased autoantibody concentrations due to adenomyosis was drastically reduced by hysterectomy or danazol treatment (Figure 2) . El-Roeiy et al. (1988) reported a similar reduction in the concentration of autoanti- bodies following initiation of danazol treatment in endometriosis patients.
Autoantibodies are derived from the IgG, IgM or IgA groups. In endometriosis the concentrations of IgG and IgM have been reported to be higher in autoantibodypositive patients than in autoantibody-negative patients . We have reported that concentrations of immunoglobulins in peripheral blood are increased in adenomyosis , and IgM concentrations are decreased significantly following 8 weeks of danazol treatment, suggesting that danazol reduces the production of immunoglobulins.
Several immunohistochemical studies have shown positive staining for IgG in the glandular epithelium in endometriosis (Weed and Arquembourg, 1980; Liu et al., 1982; Saifuddin et al., 1983; Kreiner et al., 1986; Mathur et al., 1990) , and similar strong IgG staining was noted in adenomyosis (Ota and Maki, 1990) .
Anti-phospholipid antibodies are often present in patients with autoimmune diseases, including systemic lupus erythematosus (Fort et al., 1987) and rheumatoid arthritis (Manoussakis et al., 1987) . More recently, it has been demonstrated that women with positive autoantibody titres have a higher incidence of miscarriage (Gleicher et al., 1989; Balasch et al., 1990) . There is controversy concerning the likely effect of autoantibodies on in-vitro fertilization (IVF) success rates. Low pregnancy rates have been reported in patients with positive autoantibody titres compared with autoantibodynegative patients Sher et al., 1994; Dmowski et al., 1995) , while others report satisfactory results irrespective of the presence of autoantibodies (Fisch et al., 1991; Gleicher et al., 1994) . There is still insufficient knowledge of the effect of autoantibody titers on IVF outcome in endometriosis patients.
Complements
These are complex arrangements of proteins that interact with immunoglobulins to complete an antigen-antibody response (Cole and Colten, 1988) . Assuming the immune system to be activated in adenomyosis, it is possible that the adherence of complement components to endometrial cells plays a role. We have found that in normal fertile women the deposition of complement components is rare, while the deposition of complement components C3 or C4 in adenomyosis is increased in 74% and 89% of patients respectively (Ota and Maki, 1990) . Deposition of complement has also been found in the endometrium in endometriosis (Weed and Arqembourg, 1980; Bartosik et al., 1987) . Hence the complement system may be involved in an abnormal immune response, and complement deposition in the endometrium may occur in patients with in adenomyosis and endometriosis.
Intracellular response of endometrial cells Heat shock proteins (HSP)
HSP are synthesized when any living cell or organism is exposed to a variety of physical and chemical stimuli, including heat shock, steroids, and oxidative damage (Jacquier-Sarlin et al., 1994) . They play an essential role as molecular chaperones in the folding of newly synthesized proteins within cells (Feige and Mollenhauer, 1992) . Moreover, it has been reported that subsets of γδT cells can recognize HSP65 or HSP70 as specific antigens (Beagley et al., 1993) . Thus, HSP may work as ligands of γδT cells. We have reported the strong expression of HSP, particularly HSP27, in endometriosis and adenomyosis . HSP70 has been shown to be strongly expressed in infertile women, including those with endometriosis, compared with controls (Nip et al., 1994) . Substantial evidence for the participation of HSP in various autoimmune diseases has been reported in the literature (Yang and Feige, 1992; Brudzynski et al., 1992) . How HSP are involved in abnormal autoimmune phenomena is not clear, but they may act via their role as molecular chaperones. An increase in intracellular HSP might be implicated in the immune response mediated by macrophages and/or T cells in endometriosis or adenomyosis.
Adenomyosis and infertility
Until recently, scant attention has been paid to the possible relationship between adenomyosis and infertility (Dougherty and Anderson, 1964; Nikkanen and Punnonen, 1980) , and only case reports are available (Honoré et al., 1988; Hirata et al., 1993; Nelson and Corson, 1993; Silva et al., 1994) . Several reasons for this lack of information have been cited. The incidence of adenomyosis begins to rise from the age of the mid-thirties. Moreover, it is difficult to diagnose adenomyosis before surgery, because there are no pathognomonic signs, symptoms, or physical findings. However, recent developments in methods of evaluation including the measurement of CA125, hysteroscopy (Ota, 1992) , and particularly magnetic resonance imaging, have shown the importance of adenomyosis in infertile patients (McCarthy, 1990; Woodward et al., 1993; de Souza et al., 1995) .
It has been reported that miscarriage rates in patients with endometriosis are high, ranging from 11 to 63% (Daya, 1994) . Treatment with danazol of endometriosis patients reduces this rate to an average of 11%. Another report has suggested the possible involvement of adenomyosis in infertility and early miscarriage (Olive et al., 1982; Kano et al., 1997; Parazzini et al., 1997) . However, the mechanisms that cause infertility or induce early miscarriage in adenomyosis are unknown. It is possible that nitric oxide, a potential vasodilator, might be involved in the mechanisms. Recent reports indicate that endothelial nitric oxide synthase, originally identified in vascular en- dothelial cells, is present in glandular epithelial cells in the endometrium (Tseng et al., 1996; Telfer et al., 1997) . Further, the expression of endothelial nitric oxide synthase in the endometrium varies with the menstrual cycle, and is most marked in the mid-secretory phase in fertile women. In contrast, the expression of the enzyme in adenomyosis is persistently high compared with controls throughout the menstrual cycle (Ota et al., 1998) . Furthermore, several studies in vitro indicate that nitric oxide affects both human spermatozoa (Rosselli et al., 1995; Zini et al., 1995) and rat embryos (Lee and Juchau, 1994) , and that optimal levels of nitric oxide are critical for normal sperm function and embryonic development. As we have already mentioned, the endometrial environment in patients with adenomyosis has different immune parameters from those in normal fertile women. These abnormal immune responses might eventually stimulate macrophages and/or endometrial cells to produce persistently large amounts of nitric oxide and hence impede fertilization and/or implantation. Even after successful implantation, the embryo may be attacked by activated macrophages or T cells and/or exposed to an excess of nitric oxide, resulting in early miscarriage.
Conclusion
In adenomyosis, a series of immune responses is activated. These include a strong expression of cell surface antigens, an increase in the number of macrophages or immune cells, and the deposition of immunoglobulins and complement components. Thus, endometrial cells are under immunological stress, and protect themselves by synthesizing HSP. Furthermore, activated immune cells secrete different cytokines or growth factors, which stimulate the expression of cell surface antigens, resulting in an immunological 'vicious circle' (Figure 3) . Further studies are needed to improve fecundity in patients with adenomyosis and to find better treatments to relieve their clinical symptoms.
